Cervical HPV treatment suppository

Abstract

The utility model discloses a cervical HPV (human papilloma virus) treatment suppository which comprises a supporting part, a second sleeve and an atomizing spray pipe, a first sleeve is arranged on the supporting part, and the first sleeve penetrates through the supporting part and extends outwards to be connected with a limiting head arranged at the end of the supporting part; an operating handle is arranged at the end part of the second sleeve, the operating handle is arranged in the limiting head in a penetrating manner, the second sleeve is arranged in the first sleeve in a penetrating manner, and an activated carbon fiber coating layer for adhering secretions is arranged on the part, extending outwards from the inside of the first sleeve, of the second sleeve; the atomizing spray pipe is arranged in the second sleeve in a penetrating mode, one end of the atomizing spray pipe is provided with an oval atomizing spray head, the other end of the atomizing spray pipe is provided with a connector used for being connected into an atomizing pipe of an atomizing machine, and the connector is arranged in the operating handle in a penetrating mode. A combined design structure is adopted, the affected part of a patient can be cleaned, atomized and sprayed, atomized medicine is fully exerted to directly reach the affected part, and the treatment effect is improved.

Description

Technical Field

[0001] The utility model relates to the technical field of HPV treatment, in particular to a cervical HPV treatment plug. Background Art

[0002] HPV, short for human papillomavirus, is a sexually transmitted disease caused by a spherical DNA virus. Depending on the type of HPV, it can be divided into low-risk and high-risk types for the skin, and low-risk and high-risk types for the mucous membranes. Clinically, surface diseases can manifest as common warts or flat warts, and can even be associated with malignant tumors, such as cervical cancer, a common gynecological condition. This explains the increasing attention being paid to HPV infection. If infected with HPV, it is imperative to promptly seek systematic treatment at a local hospital to avoid delaying the disease. For low-risk HPV, boosting immunity is generally recommended for self-healing. For high-risk HPV, various treatments are available, including oral medications, topical gels, and electrocautery. A combination of oral and topical treatments is common. For topical gels, nurses use a medication stick to deliver the gel to the affected area. However, observation of multiple clinical cases over treatment cycles revealed that direct delivery of the gel stick to the affected area can be blocked by secretions, preventing the drug from reaching the affected area and significantly reducing the effectiveness of the treatment. Utility Model Content

[0003] The purpose of the present utility model is to provide a cervical HPV treatment plug in order to solve the above problems.

[0004] The utility model achieves the above-mentioned purpose through the following technical solutions:

[0005] A cervical HPV treatment suppository, comprising:

[0006] A support portion, wherein a first sleeve is provided on the support portion, and the first sleeve extends outward through the support portion and is connected to a limit head provided at an end of the support portion;

[0007] A second sleeve, wherein an operating handle is provided at the end of the second sleeve, the operating handle is inserted into the limit head, the second sleeve is inserted into the first sleeve, and the portion of the second sleeve extending outward from the first sleeve is provided with an activated carbon fiber coating for adhering secretions;

[0008] And an atomizing nozzle, the atomizing nozzle is inserted into the second sleeve, one end of the atomizing nozzle is provided with an elliptical atomizing nozzle, the other end of the atomizing nozzle is provided with a connector for connecting to the atomizing pipe of the atomizer, and the connector is inserted into the operating handle.

[0009] Preferably, the support portion is an arc-shaped support cover for closely adhering to the affected part of the patient, the arc-shaped support cover and the limiting head are an integral injection-molded structure, and the limiting head is provided with anti-slip grooves.

[0010] Preferably, the cross-section of the end of the first sleeve away from the limiting head is in the shape of a bullet head.

[0011] Preferably, a limiting chuck is provided between the operating handle and the second sleeve, a limiting groove for accommodating the limiting chuck is provided in the limiting head, and the limiting chuck is inserted into the limiting groove.

[0012] Preferably, a pull ring is detachably provided on the end of the operating handle.

[0013] Preferably, the width of the elliptical atomizing nozzle is greater than the diameter of the first sleeve.

[0014] The beneficial effects of the present invention are:

[0015] 1. The utility model is installed in sequence by installing the support part, the first sleeve, the second sleeve and the atomizing nozzle, that is, after the second sleeve is inserted into the first sleeve, the atomizing nozzle is inserted into the second sleeve. Since the atomizing nozzle at the end of the atomizing nozzle is larger, an inverted installation method is adopted, that is, the atomizing nozzle is inserted into the second sleeve from the end of the second sleeve, and the atomizing nozzle passes through the support part and then into the pull ring, and the pull ring is inserted into the operating handle. Thus, the installation is completed. The overall structural design is ingenious, the assembly is simple, and the operation is convenient.

[0016] 2. The utility model utilizes the activated carbon fiber coating layer provided on the second sleeve to quickly absorb the adverse secretions on the patient's site, thereby improving the cleanliness of the patient's site and the environment of the patient's site. The atomizing nozzle is used to spray the atomized medicine on the patient's site to avoid the obstruction of secretions. The atomized medicine can directly reach the patient's site, which helps the patient's site absorb the medicine and greatly improves the treatment effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0018] Figure 1 It is a schematic diagram of the overall assembly structure of the utility model.

[0019] Figure 2 It is a structural diagram of the second sleeve in the utility model.

[0020] Figure 3 It is a structural diagram of the atomizing nozzle in the utility model.

[0021] The following are the descriptions of the reference numerals:

[0022] 1 is the supporting part, 2 is the first sleeve, 3 is the second sleeve, 4 is the activated carbon fiber coating layer, 5 is the atomizing nozzle, 6 is the atomizing nozzle, 7 is the limiting head, 8 is the operating handle, 9 is the pull ring, and 10 is the limiting chuck. DETAILED DESCRIPTION

[0023] The following is combined with Figure 1-3 , the technical solution of the utility model is further explained:

[0024] like Figure 1 As shown, the utility model discloses a cervical HPV treatment plug, comprising a support portion 1, a second sleeve 3, and an atomizing nozzle 5. The support portion 1 is provided with a first sleeve 2, which extends outward through the support portion 1 and is connected to a limit head 7 provided at the end of the support portion 1. In other words, the first sleeve is provided on one side of the support portion, and the limit head is provided on the other side of the support portion. The function of the limit head is to limit the position of the second sleeve when the second sleeve is installed. At the same time, the end of the first sleeve is provided in the limit head, and the first sleeve and the limit head form an integrated structure.

[0025] It should be noted that the limiting head 7 is communicated with the interior of the first sleeve 2 , and the barrel of the second sleeve 3 is inserted into the channel communicating with the limiting head 7 and the first sleeve 2 .

[0026] The cross-section of one end of the first sleeve 2 away from the limiting head 7 is in the shape of a bullet head. In other words, the end of the first sleeve is designed into a bullet-like elliptical shape to prevent the end of the first sleeve from scratching the patient.

[0027] In some embodiments, as Figure 1 As shown, the support portion 1 is an arc-shaped support cover for contact with the patient's affected area. The arc-shaped support cover and the stopper head 7 are an integrally injection-molded structure, and the stopper head 7 is provided with anti-slip grooves. In other words, the support portion design incorporates ergonomics, adopting an arc-shaped concave design as the support cover. The support cover is used to contact the patient's private parts, and the stopper head is designed with anti-slip grooves. During operation, the nurse presses the stopper head to prevent slipping, thereby pressing the support cover against the patient's private parts. At the same time, the other hand can rotate or pull the operating handle to withdraw the second sleeve from the first sleeve.

[0028] Specifically, if Figure 2As shown, an operating handle 8 is provided at the end of the second sleeve 3, and the operating handle 8 is inserted into the limit head 7; that is, an operating handle is provided at the tail end of the second sleeve, so that the nursing staff can hold the operating handle to perform operations such as rotation and pulling, and the operating handle is inserted into the limit head, and the limit head is used to limit and support the operating handle.

[0029] In some embodiments, as Figure 2 As shown, a limit chuck 10 is provided between the operating handle 8 and the second sleeve 3. A limit groove for accommodating the limit chuck 10 is provided in the limit head 7, and the limit chuck 10 is inserted into the limit groove. In other words, a circular limit chuck is provided at the bottom of the operating handle, and a retaining ring extends outward from the circular limit chuck. An annular limit groove is provided in the limit head. The retaining ring in the limit chuck is inserted into the annular limit groove, and the annular limit groove is used to support and limit the operating handle.

[0030] It should be noted that the second sleeve 3 is located inside the clamping ring, which facilitates the second sleeve 3 to pass through the operating handle and the clamping ring.

[0031] In some embodiments, as Figure 2 As shown, the end of the operating handle 8 is detachably provided with a pull ring 9. In other words, the pull ring is also provided with a base, which is inserted into the operating handle, and the position of the atomizing nozzle can be adjusted by pulling or rotating the atomizing nozzle.

[0032] It should be noted that the diameter of the pull ring 9 is slightly larger than the diameter of the operating handle 8 .

[0033] Specifically, if Figure 1 and Figure 2 As shown, the second sleeve 3 is inserted into the first sleeve 2, and the portion of the second sleeve 3 extending outward from the first sleeve 2 is provided with an activated carbon fiber coating 4 for adhering secretions; that is, a portion of the cylinder of the second sleeve is wrapped with activated carbon fiber. The activated carbon fiber is an activated carbon-containing fiber with nano-scale pores on its surface, which has a very good adsorption effect. In military defense, it can be used to make medical gloves, dressings, bandages and medical supplies, etc. When in use, when the second sleeve is delivered to the patient's affected area, the activated carbon fiber coating adsorbs the adverse secretions from the patient's area, and then the second sleeve can be pulled out, and finally atomized spray treatment is performed.

[0034] It should be noted that when pulling out the second sleeve, you need to move slowly to avoid causing damage to the patient too quickly. At the same time, when pulling out the second sleeve, you need to remove the pull ring from the operating handle, press the limit head on the support part, and slowly pull the operating handle to pull out the second sleeve.

[0035] Specifically, if Figure 3As shown, the atomizing nozzle 5 is inserted into the second sleeve 3, and one end of the atomizing nozzle 5 is provided with an elliptical atomizing nozzle 6. In other words, the end of the atomizing nozzle is designed as an elliptical atomizing nozzle to prevent the end of the atomizing nozzle from scratching the patient during the propulsion process.

[0036] like Figure 3 As shown, the width of the elliptical atomizing nozzle 6 is greater than the diameter of the first sleeve 2. In other words, the width of the atomizing nozzle is designed to be greater than the diameter of the first sleeve to prevent the atomizing nozzle from slipping out of the first sleeve when it is subsequently withdrawn.

[0037] In some embodiments, as Figure 3 As shown, the other end of the atomizing nozzle 5 is provided with a connector for connecting to the atomizing tube of the atomizer. The connector is inserted into the operating handle 8 and abuts against the pull ring base. In other words, the other end of the atomizing nozzle is connected to the atomizing tube. When it is necessary to apply medicine to the patient's affected area, after removing the pull ring from the operating handle, the atomizing tube is inserted into the operating handle and connected to the end of the atomizing nozzle. The atomizer is then turned on to start applying medicine to the patient's affected area.

[0038] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are merely illustrative of the principles of the present invention. Various changes and improvements may be made to the present invention without departing from the spirit and scope of the present invention, and such changes and improvements shall fall within the scope of the present invention as claimed.

Claims

1. A cervical HPV treatment plug, characterized in that: include: A support portion, wherein a first sleeve is provided on the support portion, and the first sleeve extends outward through the support portion and is connected to a limit head provided at an end of the support portion; A second sleeve, wherein an operating handle is provided at the end of the second sleeve, the operating handle is inserted into the limit head, the second sleeve is inserted into the first sleeve, and the portion of the second sleeve extending outward from the first sleeve is provided with an activated carbon fiber coating for adhering secretions; And an atomizing nozzle, the atomizing nozzle is inserted into the second sleeve, one end of the atomizing nozzle is provided with an elliptical atomizing nozzle, the other end of the atomizing nozzle is provided with a connector for connecting to the atomizing pipe of the atomizer, and the connector is inserted into the operating handle.

2. The cervical HPV treatment plug according to claim 1, characterized in that: The support portion is an arc-shaped support cover for closely adhering to the affected part of the patient. The arc-shaped support cover and the limiting head are an integrally injection-molded structure, and the limiting head is provided with anti-slip grooves.

3. The cervical HPV treatment plug according to claim 1, characterized in that: The cross-section of one end of the first sleeve away from the limiting head is in the shape of a bullet head.

4. The cervical HPV treatment plug according to claim 1, characterized in that: A limiting chuck is provided between the operating handle and the second sleeve, a limiting groove for accommodating the limiting chuck is provided in the limiting head, and the limiting chuck is inserted into the limiting groove.

5. The cervical HPV treatment plug according to claim 1 or 4, characterized in that: The end of the operating handle is detachably provided with a pull ring.

6. The cervical HPV treatment plug according to claim 1, characterized in that: The width of the elliptical atomizing nozzle is greater than the diameter of the first sleeve.

Images